Gene Targeting in Hematopoietic Stem Cells for Basic and Translational Research
In this webinar Dr Daniel Dever, Stanford University, describes a reproducible CRISPR-Cas9-based protocol for gene editing in hematopoietic stem cells.
Publish Date:
November 28, 2018
Related Multimedia
-
Targeting Self-Renewal Function in Normal Hematopoietic and Leukemic Stem Cells
Publish Date: February 03, 2017 -
Using CRISPR/Cas9 to Model Stem Cell Organization and Dynamics
Publish Date: August 25, 2017 -
CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells
Publish Date: June 26, 2018
